METHAZOLAMIDE - Generic Drug Details

✉ Email this page to a colleague

What are the generic sources for methazolamide and what is the scope of patent protection?

Methazolamide is the generic ingredient in two branded drugs marketed by Ani Pharms, Applied Anal, Athem, Bausch And Lomb Inc, Mikart, Sandoz, Tagi, and Lederle, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for methazolamide. Eleven suppliers are listed for this compound.

Summary for METHAZOLAMIDE

US Patents:	0
Tradenames:	2
Applicants:	8
NDAs:	8
Drug Master File Entries:	7
Finished Product Suppliers / Packagers:	11
Raw Ingredient (Bulk) Api Vendors:	117
Clinical Trials:	9
Patent Applications:	6,425
Drug Prices:	Drug price trends for METHAZOLAMIDE
What excipients (inactive ingredients) are in METHAZOLAMIDE?	METHAZOLAMIDE excipients list
DailyMed Link:	METHAZOLAMIDE at DailyMed

See drug prices for METHAZOLAMIDE

Recent Clinical Trials for METHAZOLAMIDE

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
University of Waterloo	Phase 4
Wilderness Medical Society	Phase 4
University of British Columbia	Phase 4

See all METHAZOLAMIDE clinical trials

Medical Subject Heading (MeSH) Categories for METHAZOLAMIDE

Carbonic Anhydrase Inhibitors
Diuretics

Anatomical Therapeutic Chemical (ATC) Classes for METHAZOLAMIDE

S01EC	Carbonic anhydrase inhibitors
S01E	ANTIGLAUCOMA PREPARATIONS AND MIOTICS
S01	OPHTHALMOLOGICALS
S	Sensory organs

US Patents and Regulatory Information for METHAZOLAMIDE

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Tagi	METHAZOLAMIDE	methazolamide	TABLET;ORAL	215615-001	Oct 18, 2022	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Tagi	METHAZOLAMIDE	methazolamide	TABLET;ORAL	215615-002	Oct 18, 2022	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
Bausch And Lomb Inc	METHAZOLAMIDE	methazolamide	TABLET;ORAL	207438-001	Oct 5, 2018	AB	RX	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.